<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">73245</article-id><article-id pub-id-type="doi">10.7554/eLife.73245</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-252734"><name><surname>Kerk</surname><given-names>Samuel</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9786-2245</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-12"/><xref ref-type="other" rid="par-19"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-252735"><name><surname>Lin</surname><given-names>Lin</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-252736"><name><surname>Myers</surname><given-names>Amy L</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-284227"><name><surname>Sutton</surname><given-names>Damien J</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-252757"><name><surname>Andren</surname><given-names>Anthony</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-252744"><name><surname>Sajjakulnukit</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-115879"><name><surname>Zhang</surname><given-names>Li</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-85949"><name><surname>Zhang</surname><given-names>Yaqing</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-285845"><name><surname>Jiménez</surname><given-names>Jennifer A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-252745"><name><surname>Nelson</surname><given-names>Barbara S</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-252746"><name><surname>Chen</surname><given-names>Brandon</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-252747"><name><surname>Robinson</surname><given-names>Anthony</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-252748"><name><surname>Thurston</surname><given-names>Galloway</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-252749"><name><surname>Kemp</surname><given-names>Samantha B</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-9"/><xref ref-type="other" rid="par-10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-252750"><name><surname>Steele</surname><given-names>Nina G</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-11"/><xref ref-type="other" rid="par-13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-252751"><name><surname>Hoffman</surname><given-names>Megan T</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-252752"><name><surname>Wen</surname><given-names>Hui-Ju</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-252753"><name><surname>Long</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-252754"><name><surname>Ackenhusen</surname><given-names>Sarah E</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-252755"><name><surname>Ramos</surname><given-names>Johanna</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-252756"><name><surname>Gao</surname><given-names>Xiaohua</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-252758"><name><surname>Nwosu</surname><given-names>Zeribe C</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-252759"><name><surname>Galban</surname><given-names>Stefanie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-252760"><name><surname>Halbrook</surname><given-names>Christopher J</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-14"/><xref ref-type="other" rid="par-15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-48368"><name><surname>Lombard</surname><given-names>David B</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="par-16"/><xref ref-type="other" rid="par-17"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-252761"><name><surname>Piwnica-Worms</surname><given-names>David R</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-104811"><name><surname>Ying</surname><given-names>Haoqiang</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-14008"><name><surname>Pasca di Magliano</surname><given-names>Marina</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9632-9035</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-85968"><name><surname>Crawford</surname><given-names>Howard C</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-44774"><name><surname>Shah</surname><given-names>Yatrik M</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-20"/><xref ref-type="other" rid="par-21"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-284938"><name><surname>Lyssiotis</surname><given-names>Costas A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9309-6141</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor3">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-18"/><xref ref-type="other" rid="par-22"/><xref ref-type="other" rid="par-23"/><xref ref-type="other" rid="par-24"/><xref ref-type="other" rid="par-25"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><institution content-type="dept">Doctoral Program in Cancer Biology</institution>, <institution>University of Michigan-Ann Arbor</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Molecular and Integrative Physiology</institution>, <institution>University of Michigan-Ann Arbor</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Surgery</institution>, <institution>University of Michigan-Ann Arbor</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Cell and Developmental Biology</institution>, <institution>University of Michigan-Ann Arbor</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Molecular and Cellular Pathology Graduate Program</institution>, <institution>University of Michigan-Ann Arbor</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">Program in Chemical Biology</institution>, <institution>University of Michigan-Ann Arbor</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution content-type="dept">Department of Pathology</institution>, <institution>University of Miami</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><aff id="aff8"><institution content-type="dept">Department of Cancer Systems Imaging</institution>, <institution>The University of Texas MD Anderson Cancer Center</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><aff id="aff9"><institution content-type="dept">Department of Molecular and Cellular Oncology</institution>, <institution>The University of Texas MD Anderson Cancer Center</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-126922"><name><surname>Finley</surname><given-names>Lydia W S</given-names></name><role>Reviewing editor</role><aff><institution>Memorial Sloan Kettering Cancer Center</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>hcrawfo1@hfhs.org</email> (HC);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>shahy@umich.edu</email> (YS);</corresp><corresp id="cor3"><label>*</label>For correspondence: <email>clyssiot@umich.edu</email> (CL);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>11</day><month>07</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e73245</elocation-id><history><date date-type="received"><day>21</day><month>08</month><year>2021</year></date><date date-type="accepted"><day>09</day><month>07</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Kerk et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Kerk et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-73245-v1.pdf"/><abstract><p>Mitochondrial glutamate-oxaloacetate (GOT2) is part of the malate-aspartate shuttle (MAS), a mechanism by which cells transfer reducing equivalents from the cytosol to the mitochondria. GOT2 is a key component of mutant KRAS (KRAS*)-mediated rewiring of glutamine metabolism in pancreatic ductal adenocarcinoma (PDA). Here, we demonstrate that the loss of GOT2 disturbs redox homeostasis and halts proliferation of PDA cells in vitro. GOT2 knockdown (KD) in PDA cell lines in vitro induced NADH accumulation, decreased Asp and α-ketoglutarate (αKG) production, stalled glycolysis, disrupted the TCA cycle, and impaired proliferation. Oxidizing NADH through chemical or genetic means resolved the redox imbalance induced by GOT2 KD, permitting sustained proliferation. Despite a strong in vitro inhibitory phenotype, loss of GOT2 had no effect on tumor growth in xenograft PDA or autochthonous mouse models. We show that cancer-associated fibroblasts (CAFs), a major component of the pancreatic tumor microenvironment (TME), release the redox active metabolite pyruvate, and culturing GOT2 KD cells in CAF conditioned media (CM) rescued proliferation in vitro. Furthermore, blocking pyruvate import or pyruvate-to-lactate reduction prevented rescue of GOT2 KD in vitro by exogenous pyruvate or CAF CM. However, these interventions failed to sensitize xenografts to GOT2 KD in vivo, demonstrating the remarkable plasticity and differential metabolism deployed by PDA cells in vitro and in vivo. This emphasizes how the environmental context of distinct pre-clinical models impacts both cell-intrinsic metabolic rewiring and metabolic crosstalk with the tumor microenvironment (TME).</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>T32AI007413</award-id><principal-award-recipient><name><surname>Kerk</surname><given-names>Samuel</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>R37CA237421</award-id><principal-award-recipient><name><surname>Lyssiotis</surname><given-names>Costas A</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>R01CA248160</award-id><principal-award-recipient><name><surname>Lyssiotis</surname><given-names>Costas A</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>R01CA244931</award-id><principal-award-recipient><name><surname>Lyssiotis</surname><given-names>Costas A</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>F31CA254079</award-id><principal-award-recipient><name><surname>Jiménez</surname><given-names>Jennifer A</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>T32-DK094775</award-id><principal-award-recipient><name><surname>Nelson</surname><given-names>Barbara S</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>T32-CA009676</award-id><principal-award-recipient><name><surname>Nelson</surname><given-names>Barbara S</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>R50 CA232985</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Yaqing</given-names></name></principal-award-recipient></award-group><award-group id="par-9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>T32-GM11390</award-id><principal-award-recipient><name><surname>Kemp</surname><given-names>Samantha B</given-names></name></principal-award-recipient></award-group><award-group id="par-10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>F31-CA247076</award-id><principal-award-recipient><name><surname>Kemp</surname><given-names>Samantha B</given-names></name></principal-award-recipient></award-group><award-group id="par-11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>T32-CA009676</award-id><principal-award-recipient><name><surname>Steele</surname><given-names>Nina G</given-names></name></principal-award-recipient></award-group><award-group id="par-12"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>F31CA24745701</award-id><principal-award-recipient><name><surname>Kerk</surname><given-names>Samuel</given-names></name></principal-award-recipient></award-group><award-group id="par-13"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000048</institution-id><institution>American Cancer Society</institution></institution-wrap></funding-source><award-id>PF-19-096-01</award-id><principal-award-recipient><name><surname>Steele</surname><given-names>Nina G</given-names></name></principal-award-recipient></award-group><award-group id="par-14"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>K99CA241357</award-id><principal-award-recipient><name><surname>Halbrook</surname><given-names>Christopher J</given-names></name></principal-award-recipient></award-group><award-group id="par-15"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>P30DK034933</award-id><principal-award-recipient><name><surname>Halbrook</surname><given-names>Christopher J</given-names></name></principal-award-recipient></award-group><award-group id="par-16"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>R01GM101171</award-id><principal-award-recipient><name><surname>Lombard</surname><given-names>David B</given-names></name></principal-award-recipient></award-group><award-group id="par-17"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>CA253986</award-id><principal-award-recipient><name><surname>Lombard</surname><given-names>David B</given-names></name></principal-award-recipient></award-group><award-group id="par-18"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003645</institution-id><institution>National Cancer Center</institution></institution-wrap></funding-source><award-id>P30 CA046592</award-id><principal-award-recipient><name><surname>Lyssiotis</surname><given-names>Costas A</given-names></name></principal-award-recipient></award-group><award-group id="par-19"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>1F99CA264414-01</award-id><principal-award-recipient><name><surname>Kerk</surname><given-names>Samuel</given-names></name></principal-award-recipient></award-group><award-group id="par-20"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>CA148828</award-id><principal-award-recipient><name><surname>Shah</surname><given-names>Yatrik M</given-names></name></principal-award-recipient></award-group><award-group id="par-21"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>CA245546</award-id><principal-award-recipient><name><surname>Shah</surname><given-names>Yatrik M</given-names></name></principal-award-recipient></award-group><award-group id="par-22"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001784</institution-id><institution>Pancreatic Cancer Action Network</institution></institution-wrap></funding-source><award-id>13-70-25-LYSS</award-id><principal-award-recipient><name><surname>Lyssiotis</surname><given-names>Costas A</given-names></name></principal-award-recipient></award-group><award-group id="par-23"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001368</institution-id><institution>V Foundation for Cancer Research</institution></institution-wrap></funding-source><award-id>V2016-009</award-id><principal-award-recipient><name><surname>Lyssiotis</surname><given-names>Costas A</given-names></name></principal-award-recipient></award-group><award-group id="par-24"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100011034</institution-id><institution>Sidney Kimmel Foundation</institution></institution-wrap></funding-source><award-id>SKF-16-005</award-id><principal-award-recipient><name><surname>Lyssiotis</surname><given-names>Costas A</given-names></name></principal-award-recipient></award-group><award-group id="par-25"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000043</institution-id><institution>American Association for Cancer Research</institution></institution-wrap></funding-source><award-id>17-20-01-LYSS</award-id><principal-award-recipient><name><surname>Lyssiotis</surname><given-names>Costas A</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Costas A Lyssiotis, has received consulting fees from Astellas Pharmaceuticals, Odyssey Therapeutics, and T-Knife Therapeutics, and is an inventor on patents pertaining to Kras regulated metabolic pathways, redox control pathways in pancreatic cancer, and targeting the GOT1-pathway as a therapeutic approach (US Patent No: 2015126580-A1, 05/07/2015; US Patent No: 20190136238, 05/09/2019; International Patent No: WO2013177426-A2, 04/23/2015)..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Animal experiments were conducted in accordance with the Office of Laboratory Animal Welfare and approved by the Institutional Animal Care and Use Committees of the University of Michigan. ULAM: PRO00008877</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript and supporting Source Data file; raw data are provided for metabolomics experiments, separated by tabs, in Supplemental Table 1.</p></sec><supplementary-material><ext-link xlink:href="elife-73245-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>